These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30222312)

  • 1. Studies on the Activity of Selected Highly Lipophilic Compounds toward hGAT1 Inhibition. Part II.
    Nowaczyk A; Fijałkowski Ł; Kowalska M; Podkowa A; Sałat K
    ACS Chem Neurosci; 2019 Jan; 10(1):337-347. PubMed ID: 30222312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of selected antiepileptics used in neuropathic pain as human GABA transporter isoform 1 (GAT1) inhibitors-Molecular docking and pharmacodynamic studies.
    Fijałkowski Ł; Sałat K; Podkowa A; Zaręba P; Nowaczyk A
    Eur J Pharm Sci; 2017 Jan; 96():362-372. PubMed ID: 27721044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking and pharmacodynamic studies on hGAT1 inhibition activity in the presence of selected neuronal and astrocytic inhibitors. Part I.
    Nowaczyk A; Fijałkowski Ł; Zaręba P; Sałat K
    J Mol Graph Model; 2018 Oct; 85():171-181. PubMed ID: 30219588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Dynamic Simulations to Probe Stereoselectivity of Tiagabine Binding with Human GAT1.
    Zafar S; Jabeen I
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel, highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties.
    Sałat K; Podkowa A; Malikowska N; Kern F; Pabel J; Wojcieszak E; Kulig K; Wanner KT; Strach B; Wyska E
    Neuropharmacology; 2017 Feb; 113(Pt A):331-342. PubMed ID: 27771379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure activity relationship of selective GABA uptake inhibitors.
    Vogensen SB; Jørgensen L; Madsen KK; Jurik A; Borkar N; Rosatelli E; Nielsen B; Ecker GF; Schousboe A; Clausen RP
    Bioorg Med Chem; 2015 May; 23(10):2480-8. PubMed ID: 25882526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of GABA reuptake inhibition.
    Motiwala Z; Aduri NG; Shaye H; Han GW; Lam JH; Katritch V; Cherezov V; Gati C
    Nature; 2022 Jun; 606(7915):820-826. PubMed ID: 35676483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological properties of new GABA uptake inhibitors.
    Sałat K; Więckowska A; Więckowski K; Höfner GC; Kamiński J; Wanner KT; Malawska B; Filipek B; Kulig K
    Pharmacol Rep; 2012; 64(4):817-33. PubMed ID: 23087134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents.
    Lutz T; Wein T; Höfner G; Wanner KT
    ChemMedChem; 2017 Mar; 12(5):362-371. PubMed ID: 28125164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.
    Zaręba P; Gryzło B; Malawska K; Sałat K; Höfner GC; Nowaczyk A; Fijałkowski Ł; Rapacz A; Podkowa A; Furgała A; Żmudzki P; Wanner KT; Malawska B; Kulig K
    Eur J Med Chem; 2020 Feb; 188():111920. PubMed ID: 31901745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRID-independent molecular descriptor analysis and molecular docking studies to mimic the binding hypothesis of γ-aminobutyric acid transporter 1 (GAT1) inhibitors.
    Zafar S; Jabeen I
    PeerJ; 2019; 7():e6283. PubMed ID: 30723616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine does not attenuate alcohol-induced activation of the human reward system.
    Fehr C; Hohmann N; Gründer G; Dielentheis TF; Buchholz HG; Chechko N; Yakushev I; Landvogt C; Bartenstein P; Urban R; Schreckenberger M
    Psychopharmacology (Berl); 2007 May; 191(4):975-83. PubMed ID: 17265078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA transporters as drug targets for modulation of GABAergic activity.
    Schousboe A; Sarup A; Larsson OM; White HS
    Biochem Pharmacol; 2004 Oct; 68(8):1557-63. PubMed ID: 15451399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1).
    Jurik A; Zdrazil B; Holy M; Stockner T; Sitte HH; Ecker GF
    J Med Chem; 2015 Mar; 58(5):2149-58. PubMed ID: 25679268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression.
    Sałat K; Podkowa A; Kowalczyk P; Kulig K; Dziubina A; Filipek B; Librowski T
    Pharmacol Rep; 2015 Jun; 67(3):465-72. PubMed ID: 25933955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the First Highly Subtype-Selective Inhibitor of Human GABA Transporter GAT3.
    Damgaard M; Al-Khawaja A; Vogensen SB; Jurik A; Sijm M; Lie ME; Bæk MI; Rosenthal E; Jensen AA; Ecker GF; Frølund B; Wellendorph P; Clausen RP
    ACS Chem Neurosci; 2015 Sep; 6(9):1591-9. PubMed ID: 26154082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for substrate recognition and transport of human GABA transporter GAT1.
    Zhu A; Huang J; Kong F; Tan J; Lei J; Yuan Y; Yan C
    Nat Struct Mol Biol; 2023 Jul; 30(7):1012-1022. PubMed ID: 37400655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First photoswitchable neurotransmitter transporter inhibitor: light-induced control of γ-aminobutyric acid transporter 1 (GAT1) activity in mouse brain.
    Quandt G; Höfner G; Pabel J; Dine J; Eder M; Wanner KT
    J Med Chem; 2014 Aug; 57(15):6809-21. PubMed ID: 25025595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoalgesia in mice lacking GABA transporter subtype 1.
    Xu YF; Cai YQ; Cai GQ; Jiang J; Sheng ZJ; Wang ZG; Fei J
    J Neurosci Res; 2008 Feb; 86(2):465-70. PubMed ID: 17918738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Characterization of a Betaine/GABA Transporter 1 (BGT1) Inhibitor Displaying an Unusual Biphasic Inhibition Profile and Anti-seizure Effects.
    Lie MEK; Kickinger S; Skovgaard-Petersen J; Ecker GF; Clausen RP; Schousboe A; White HS; Wellendorph P
    Neurochem Res; 2020 Jul; 45(7):1551-1565. PubMed ID: 32248400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.